Valuation: PHARMAGEST INTER.

Market Cap 403M 442M 372M 336M 633M 41.27B 658M 4.5B 1.78B 22.28B 1.66B 1.62B 70.35B P/E 2026 *
9.11x
P/E 2027 * 8.32x
Enterprise Value 317M 348M 293M 265M 498M 32.5B 518M 3.54B 1.4B 17.54B 1.3B 1.28B 55.4B EV / Sales 2026 *
1.26x
EV / Sales 2027 * 1.1x
Free-Float
31.97%
Yield 2026 *
5.37%
Yield 2027 * 5.53%
Manager TitleAgeSince
Chief Executive Officer 57 2022-04-21
Director of Finance/CFO - 2022-12-31
Chief Tech/Sci/R&D Officer - 2018-06-30
Director TitleAgeSince
Chairman 61 2026-06-24
Director/Board Member 58 2011-06-15
Director/Board Member 57 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-7.54%-20.84%+48.69% 218B
-2.25%-13.51%-19.25%-16.25% 160B
-3.89%-9.56%-4.41%-30.67% 141B
+6.79%-3.52%+54.63%+317.39% 102B
+2.44%-7.59%+9.37%+66.95% 96.2B
-1.13%-3.87%-23.30%-32.06% 93.19B
-0.67%-1.20%-3.04%-0.67% 68.62B
-1.88%-3.93%-26.45%-22.87% 48.99B
-0.81%-4.43%-16.29%+2.72% 39.27B
Average -0.28%-2.40%-5.51%+37.03% 108B
Weighted average by Cap. -0.49%-2.67%-6.30%+39.75%

Financials

2026 *2027 *
Net sales 252M 276M 233M 210M 395M 25.77B 411M 2.81B 1.11B 13.91B 1.03B 1.01B 43.92B 266M 292M 246M 222M 419M 27.3B 435M 2.98B 1.18B 14.74B 1.1B 1.07B 46.54B
Net income 42.95M 47.09M 39.71M 35.84M 67.5M 4.4B 70.16M 480M 190M 2.38B 177M 173M 7.5B 48M 52.63M 44.38M 40.05M 75.43M 4.92B 78.41M 536M 212M 2.65B 197M 193M 8.38B
Net Debt -85.6M -93.86M -79.15M -71.43M -135M -8.77B -140M -956M -378M -4.73B -352M -345M -14.95B -110M -121M -102M -92.16M -174M -11.32B -180M -1.23B -488M -6.11B -454M -445M -19.29B
Logo PHARMAGEST INTER.
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (72.8%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.9%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (6.2%): digital communication, telemedicine and telehealth solutions; - software publishing for private practitioners and medical assistants (4.2%); - development of financing solutions for leased goods (0.9%; Nanceo). Net sales are distributed geographically as follows: France (87.5%), Italy (6.1%), Belgium (3%), Germany (2.5%), the United Kingdom (0.8%), and Ireland (0.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - PHARMAGEST INTER.